If you are an American citizen, you have already paid for your novel coronavirus vaccine. Not only have you paid for this future vaccine, you have also paid billions for the research that invented that vaccine. Pharmaceutical companies that accept all that free money to do research will turn your investment into millions. You will find a jaw in the hand.
One of the leading candidates for Phase III clinical trials is the Modern NIH vaccine. In normal times with any other disease, U.S. The government throws up a lot of money for clinical research at an early stage, which is then purchased by pharmaceutical companies that conduct Phase II and III clinical trials. When that drug comes on the market, the big pharma companies turn to it and sell it to Americans at inflated prices. Pharmaceutical companies will argue that they need to take a lot of money to improve the cost of drug development and so they can pay to find new ones.
That seems reasonable, except for the fact that it was Uncle Sam who paid for some of the drug development costs in the first place. The difference between normal time and covid time is that in the case of the modern vaccine, U.S. Government Absolute Bill.
Moderna is part of the War Operation Warp Speed, a government program that throws in literally billions to find a cure and vaccine for COVD-19. The pharmaceutical giant received about એક 1 billion for vaccine research and development earlier this year. As part of their government contract, they state how much funding they are researching out of their own money. Only after public pressure did they release a small press statement in which they admitted that Uncle Sam was paying 100% of the cost of vaccine development. Modern has invested almost zero dollars in its development. Zilch. Zero. Nada.
But it gets better. Trump has said on the trail of the campaign that the vaccine will be made available to all Americans free of charge, which is a fragrant thing to do. His administration also pre-ordered 100 million doses at a cost of 1.5 1.5 billion. This would seem reasonable as it costs money to make the vaccine. You have to put them in a few glass vials and store them at the right temperature. The point is, 1.5 billion is not the cost of vaccine production.
During a committee meeting in July, Representative Jan Skakowski asked Stephen Hodge, President of Moderna, whether they would sell the vaccine at production cost, that is, “at a price.”
His answer: “No, ma’am.”
Moderna is making millions of people a vaccine they didn’t pay to develop.
Moderna has also said they will not apply their patents during the epidemic. It’s like saying you’re a great person to lend your car to your friend and allow you to use all your gas, when it’s actually your parents who bought the car and who paid for your gas. Another small twist to the story is that Moderna didn’t even have all the patents for his covid vaccine. It takes about 18 months for a patent to be approved, and most of this material has only evolved in the last nine months, so it’s really hard right now to get a clear picture of who owns the pharmaceutical company. They have already lost their patent dispute with another pharmaceutical company, which means they would have lost anyway if they had tried to enforce some of their patent rights. But hey, giving something like something for good publicity that didn’t start with you.
The second twist is that it’s not the patents that make the most difference when it comes to making vaccines. Granting patent rights means that another company will not sue to make the vaccine and save lives, but it will help other vaccine manufacturers understand how to make these things. For that you need to know-how transfer. For those of you who watch “The Great British Back-Watch F,” it’s like another challenge, when Paul tells Hollywood bakers to make something incredibly difficult and gives them all the ingredients and minimal instruction. The recipe might say: “Mix your ingredients and fill to a temperature of 0 degrees degrees” but if you don’t know the order of the mixture, or whether you should bake in a hot water bath, you won’t get good results. No one wants to get a COVID vaccine in their hand which is the equivalent of a cooked rainbow bagel. We all want soft, moist rainbow bagel vaccine vaccines, and that is not going to happen unless pharma companies provide that information.
Fortunately, there are tools available to philanthropic pharmaceutical companies that want to grant their own patents and know how to ensure consistent global use in vaccines. WHO’s Covid-19 Technology Access G Access Pool (C-TAP) and Medicines Patent Pool are organizations that integrate intellectual property (IP), data and how-to open platforms so that scientists around the world can access information faster. Drug detection.
However, one would be surprised that not a single pharmaceutical company has contributed to any significant intellectual property in Operation Vorp Speed or known for the Covid-19 vaccine in the C-TTP or Medicines patent pool.
The chief executive of AstraZeneca, another pharmaceutical company that has received એક 1 billion for the COVID vaccine from the US government, said: [intellectual property] Is a fundamental part of our industry and essentially no one is encouraged to innovate if you do not protect IP. “Maybe literally a billion dollars isn’t encouraging enough?
When the epidemic began, there was a push for unity for a “People’s Vaccine” that would be funded by the government and provided free of charge to citizens. Unfortunately these optimistic promises have not been fulfilled. Oxfam reported that rich countries like the UK have reserved five doses of the vaccine per person, while poor countries like Bangladesh have so far received one dose per nine people. It may make sense that pharmaceutical companies are entrusted with the responsibility of research and manufacture of vaccines. That’s what they finally do. But if we want to believe in capitalism to save us from, well, capitalism, we must go ahead and let the fully developed venture capitalist on them. We should reduce profits if we invest in their research. In 2019, the top ten pharmaceutical companies had a net profit of 86 86 billion. That fraction would be enough to ensure that children in Bangladesh get the same vaccine as children in Texas.